Sonablate Corp.
Biotechnology company · Charlotte, North Carolina, United States
Sonablate Corp. is a biotechnology company headquartered in Charlotte, North Carolina, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $377,000 sold in a notice filed in 2023.
Sonablate at a glance
What does Sonablate do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $377,000 sold (2023).
Frequently asked questions about Sonablate
Where is Sonablate headquartered?
Sonablate Corp. is headquartered in Charlotte, North Carolina, United States.
What does Sonablate do?
Sonablate Corp. is a biotechnology company.
When was Sonablate founded?
The earliest incorporation on record for Sonablate Corp. is in 2021, according to public company registers.
Similar companies
- Adaptin Bio, Inc.Charlotte, North Carolina, United States
- Chelsea Therapeutics International, Ltd.Charlotte, North Carolina, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences